Nusbickel Thomas 4
4 · CorMedix Inc. · Filed Feb 23, 2022
Insider Transaction Report
Form 4
CorMedix Inc.CRMD
Nusbickel Thomas
EVP, Chief Commercial Officer
Transactions
- Award
Stock Option (Right to Buy Common Stock)
2022-02-18+100,000→ 100,000 totalExercise: $4.03Exp: 2032-02-18→ Common Stock (100,000 underlying)
Holdings
- 7,500
Stock Option (Right to Buy Common Stock)
Exercise: $7.56Exp: 2031-05-13→ Common Stock (7,500 underlying) - 260,000
Stock Option (Right to Buy Common Stock)
Exercise: $7.56Exp: 2031-05-13→ Common Stock (260,000 underlying)
Footnotes (3)
- [F1]These options were granted on 02/18/2022. These options vest 1/4 on the date of grant, 1/4 on the first anniversary of the date of grant, 1/4 on the second anniversary of the date of grant and 1/4 on the third anniversary of the date of grant.
- [F2]The options vest as follows: 160,000 will vest over four years in four (4) equal installments on the first four anniversaries of May 13, 2021. The remaining 100,000 options vest on the achievement of certain milestones, subject to continued employment.
- [F3]These options were granted on May 13, 2021. These options shall vest in full on the first anniversary of the grant date, subject to continued employment.